Scientific Program
Get inspired by the best and brightest minds in Stem Cell & Cancer research at the International Symposium in Heidelberg.
Pre-Meeting: AML Workshop
Sep 14, 2025
11:00 - 12:35
AML Workshop Part 1
- 11:00   Welcome and Opening Remarks (Carsten Müller-Tidow, Heidelberg)
- 11:05 Â Â Novel stemness regulators in acute myeloid leukemia (Caroline Pabst, Heidelberg)
- 11:30 Â Â MAC-Scoring predicts AMLs outcome with HMA/Venetoclax (Simon Renders & Alexander Waclawiczek, Heidelberg)
- 11:55 Â Â Short Talk 1: Disrupting tRNA modifications to target mitochondrial vulnerabilities in drug-resistant leukemia cells (Cornelius Pauli, Heidelberg)
- 12:10 Â Â Immunotargeting of HSPCs and AML (Markus Manz, Zurich)
- 12:35 Â Â LUNCH BREAK
Sep 14, 2025
13:20 - 14:30
AML Workshop Part 2
- 13:30 Â Â Development of new therapies based on alloreactive responses to AML (Paresh Vyas, Oxford)
- 13:55Â Â Short Talk 2: Acute myeloid leukemia with UBTF tandem duplications respond to combined BCL-2 and RNA polymerase I inhibition with increased stemless and a quiescent-like state (Nesrine Aroua, Heidelberg)
- 14:10 Â Â Cell therapy of myeloid malignancies (Saar Gill, Philadelphia)
- 14:35 Â Â Podium Discussion: Future of AML therapies (invited workshop speakers & Andrew Wei)
- 15:10 Â Â GROUP PICTURE AML WORKSHOP
- 15:30 Â Â END OF CLINICAL WORKSHOP - COFFEE BREAK
Content wird geladen. Bitte warten!
Symposium
Sep 14, 2025
16:00 - 19:30
Symposium on Stem Cells and Cancer Part 1
- 16:00   Welcome by Carsten Müller-Tidow & Andreas Trumpp
- 16:10Â Â Welcome Note by Michael Baumann, CEO& Scientific Director DKFZ
- 16:15Â Â Keynote Lecture: New direction and challenges in AML therapy (Andrew Wei, Melbourne)
- 16:55 Â Â From single.cell landscapes to data-driven cancer taxonomies and precision medicine (Simon Haas, Berlin)
- 17:25 Â Â Cancer neuroscience: how stem-like cancer cells are governed by neural features (Frank Winkler, Heidelberg)
- 17:55   Mechanisms driving clonal hematopoiesis and impact on distal tissues (Margaret Goodell, Houston)
- 18:25Â Â WELCOME RECEPTION
- 19:30 Â Â END OF DAY 1
Sep 15, 2025
09:00 - 10:40
Symposium on Stem Cells and Cancer Part 2
- 09:00 Â Â Keynote Lecture: Therapeutic targeting of chromatin complexes in leukemia (Scott Armstrong, Boston)
- 09:40 Â Â Novel approaches to target cell states in metastatic colorectal cancer (Rene Jackstadt, Heidelberg)
- 10:10 Â Â Tumor cell plasticity in colorectal cancer (Fred de Sauvage, San Francisco)
- 10:40 Â Â COFFEE BREAK
Sep 15, 2025
11:10 - 13:00
Symposium on Stem Cells and Cancer Part 3
- 11:10 Â Â Systematic impact of metastasis over host metabolism (Salvador Aznar Benitah, Barcelona)
- 11:40 Â Â Short Talk 3: Endosomal pH: A key driver in leukemic stem cell dynamics (Eleni Besiridou, Heidelberg)
- 11:55 Â Â Acute myeloid leukemia genomics: Thinking outside of box (Ann-Kathrin Eisfeld, Columbus)
- 12:25 Â Â Ten Lightning Talks - poster teasers - Ã 1 minute
- 13:00Â Â GROUP PICTURE, LUNCH BREAK, EXHIBITION
Sep 15, 2025
13:45 - 16:45
Symposium on Stem Cells and Cancer Part 4
- 14:00Â Â Poster Session 1 (odd numbered posters) and Exhibition
- 15:15Â Â Decoding and engineering T cell immunity against blood cancers (Mirco Friedrich, Heidelberg)
- 15:45Â Â Short Talk 4: Tet2 clonal hematopoiesis as a mechanistic driver of diet-induced liver cancer (Lina Merg, Heidelberg)
- 16:00Â Â DNMT3A-R882 mutation drives maladaptive myelopoiesis from human hematopoietic stem cells (Elisa Laurenti, Cambridge)
- 16:30Â COFFEE BREAK
Sep 15, 2025
17:15 - 18:00
Symposium on Stem Cells and Cancer Part 5
- 17:00Â Â Regulation of cellular plasticity in cancer (Moritz Mall, Heidelberg)
- 17:30Â Â Single cell and synthetic genomics of blood formation (Lars Velten, Barcelona)
- 18:00 Â Â END OF DAY 2
Sep 16, 2025
09:00 - 11:10
Symposium on Stem Cells and Cancer Part 6
- 09:00 Â Â Tissue stem cells: Acquiring, remembering and recalling past experiences in sickness and in health (Elaine Fuchs, New York)
- 09:40 Â Â Metabolic signaling and metastasis (Sarah-Maria Fendt, Leuven)
- 10:10Â Â Modulation of bone marrow hematopoietic stem cell activity as a therapeutic strategy after myocardial infarction: a preclinical study (Nina Cabezas-Wallscheid, Zurich)
- 10:40Â Â Perils and promise of unlocking stemness in the adult and aging brain (Ana Martin-Villalba, Heidelberg)
- 11:10Â Â Â COFFEE BREAK
Sep 16, 2025
11:40 - 13:10
Symposium on Stem Cells and Cancer Part 7
- 11:40   Small non-coding RNAs drive leukemogenesis via rRNA modifications and chromatin functions (Carsten Müller-Tidow, Heidelberg)
- 12:10 Â Â Stem Cell Pathways Aging and Cancer Evolution (Catriona Jamison, San Diego)
- 12:40 Â Â Short Talk 5: Combination of phenotypic drug screening and a WNT signaling reporter to identify stemness-targeting drugs against colorectal cancer (Martina Zowada, Heidelberg)
- 12:55 Â Ten Lightning Talks - poster teasers - Ã 1 minute
- 13:25 Â Â LUNCH BREAK and EXHIBITION,Â
Sep 16, 2025
14:00 - 17:15
Symposium on Stem Cells and Cancer Part 8
- 14:15Â Â Poster Session 2 (even numbered posters) and Exhibition
- 15:30Â Â IDH inhibition in AML (Paresh Vyas, Oxford)
- 16:00Â Â Targeting innervating peripheral neurons in pancreatic cancer (Andreas Trumpp, Heidelberg)
- 16:30Â Â Targeting RNA modifications in cancer (Michaela Frye, Heidelberg)
- 17:00  Poster Prizes & Best Short Talk (Concluding Remarks: Carsten Müller-Tidow and Andreas Trumpp)
- 17:30Â Â Â END OF CONFERENCE
Content wird geladen. Bitte warten!